Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors

Clinical trial NCT01765790 · COMPLETED

Trial details

NCT number: NCT01765790
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Adenocarcinoma of the Colon or Rectum Malignant Solid Tumors

Start date: 2012-06-14
Primary completion: 2016-07-28
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.